Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00571077 · ClinicalTrials.gov registry record

Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study

A clinical trial of Thyroid Neoplasms and Thyroid Nodules, sponsored by Hadassah Medical Organization.

Completed
Registry status
200
Enrollment target
2
Study locations

NCT00571077 is a study of Thyroid Neoplasms and Thyroid Nodules that has completed, run by Hadassah Medical Organization. The registered enrollment target is 200 participants, below the 811-participant average among 7 other Thyroid Neoplasms trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00571077, a study of Thyroid Neoplasms and Thyroid Nodules, has completed, sponsored by Hadassah Medical Organization.

COMPLETED
Registry status
200 participants
Enrollment target
2
Study locations

Study Summary

Patients over the age of 18 with thyroid nodules scheduled for surgery will undergo EIS scan. Each node will be scanned and graded form 1-5 (1=benign, 5=malignant). Results will be compared with final histopathology.

Interventions

  • DEVICE Electrical Impedance Scanning (EIS) of the Thyroid gland

Study Locations (2)

District of Columbia

  • Walter Reed Army MEdicla Center - Washington D.C.

Other

  • Hadassah-Hebrew University Medical Center - Jersualem

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2002-01
Est. Completion 2007-12

Sponsor

Hadassah Medical Organization

2 total trials

What the Registry Record Tells You About NCT00571077

The ClinicalTrials.gov registry entry for NCT00571077 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 811-participant average among 7 other Thyroid Neoplasms trials with a reported enrollment target (75% lower). The listed sponsor is Hadassah Medical Organization, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Thyroid Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Electrical Impedance Scanning (EIS) of the Thyroid gland is the first listed.

NCT00571077 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Other.

Frequently Asked Questions

What is clinical trial NCT00571077 about?

NCT00571077 is a clinical study titled "Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study". Patients over the age of 18 with thyroid nodules scheduled for surgery will undergo EIS scan. Each node will be scanned and graded form 1-5 (1=benign, 5=malignant). Results will be compared with final histopathology.

What is the current status of trial NCT00571077?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2002-01. Estimated completion is 2007-12.

What conditions does trial NCT00571077 study?

This clinical trial studies the following conditions: Thyroid Neoplasms, Thyroid Nodules.

What interventions are being tested in trial NCT00571077?

The interventions under investigation include: Electrical Impedance Scanning (EIS) of the Thyroid gland (DEVICE).

Who is sponsoring clinical trial NCT00571077?

This trial is sponsored by Hadassah Medical Organization, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00571077 being conducted?

This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.